CX-036651

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Wed Apr 02 17:32:45 GMT 2025` Edited by `admin` on `Wed Apr 02 17:32:45 GMT 2025`
Nucleic Acid Type	mRNA VACCINE
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	64GK6D44AB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CX-036651

Code

English

RNA (recombinant 5?-(m7G-(5??5?)-ppp-Gm)-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 pre-fusion spike glycoprotein [981-proline,982-proline] BQ.1.1 variant plus 5?- and 3?-untranslated flanking re

Preferred Name

English

Code System Code Type Description

FDA UNII

64GK6D44AB

Created by admin on Wed Apr 02 17:32:45 GMT 2025 , Edited by admin on Wed Apr 02 17:32:45 GMT 2025

PRIMARY

CAS

2918981-85-6

Created by admin on Wed Apr 02 17:32:45 GMT 2025 , Edited by admin on Wed Apr 02 17:32:45 GMT 2025

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_4092	4092 / 4092

Linkage	Site Range	Site Count
Phosphate	1_2-1_4092	4091 / 4091

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Related Record Type Details


					64GK6D44AB

CX-036651

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOTIDE SUBSTITUTION	[1_1]	5'-TERMINUS			5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE	T0HQY09X7B
NUCLEOSIDE_SUBSTITUTION			U		N1-METHYLPSEUDOURIDINE	09RAD4M6WF